DAVITA INC. Cost-method Investments, Aggregate Carrying Amount, Not Evaluated for Impairment
DAVITA INC. (DVA) had Cost-method Investments, Aggregate Carrying Amount, Not Evaluated for Impairment of $12.39 million as of 2018-12-31, per its 10-K filed 2019-02-22.
Discontinued › Notes › Investments
us-gaap:CostMethodInvestmentsAggregateCarryingAmountNotEvaluatedForImpairment · last filed 2019-02-22
- 2018-12-31: Cost-method Investments, Aggregate Carrying Amount, Not Evaluated for Impairment $12.39M.
- 2018-09-30: Cost-method Investments, Aggregate Carrying Amount, Not Evaluated for Impairment $12.39M.
- 2018-06-30: Cost-method Investments, Aggregate Carrying Amount, Not Evaluated for Impairment $12.39M.
- 2018-03-31: Cost-method Investments, Aggregate Carrying Amount, Not Evaluated for Impairment $5.39M.
| Period end | Cost-method Investments, Aggregate Carrying Amount, Not Evaluated for Impairment |
|---|---|
| 2018-12-31 | $12.39M 10-K · filed 2019-02-22 |
| 2018-09-30 | $12.39M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $12.39M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $5.39M 10-Q · filed 2018-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |